Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
SRx Health Solutions, Inc. issued 22,237,666 Warrants to purchase shares of Common Stock of warrant to accredited investors named therein for aggregate proceeds of approximately $4.528 million, paid in cash.
- Security
- warrant
- Shares
- 22,237,666 Warrants to purchase shares of Common Stock
- Purchaser
- accredited investors named therein
- Consideration
- aggregate proceeds of approximately $4.528 million, paid in cash
Exact text from the filing
On March 16, 2026 at the initial closing, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 5,660 shares of the Series B Preferred Stock and 22,237,666 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $4.528 million, paid in cash.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
SRx Health Solutions, Inc. issued 5,660 shares of the Series B Preferred Stock of preferred stock to accredited investors named therein for aggregate proceeds of approximately $4.528 million, paid in cash.
- Security
- preferred stock
- Shares
- 5,660 shares of the Series B Preferred Stock
- Purchaser
- accredited investors named therein
- Consideration
- aggregate proceeds of approximately $4.528 million, paid in cash
Exact text from the filing
On March 16, 2026 at the initial closing, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 5,660 shares of the Series B Preferred Stock and 22,237,666 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $4.528 million, paid in cash.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
SRx Health Solutions, Inc. entered into Securities Purchase Agreement with certain accredited investors named therein valued at up to $8.0 million (effective 2026-03-16).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain accredited investors named therein
- Value
- up to $8.0 million
- Effective
- 2026-03-16
Exact text from the filing
On March 16, 2026, SRx Health Solutions, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors named therein. Pursuant to the Securities Purchase Agreement, up to 10,000 shares of the Company’s Series B convertible preferred stock, par value $0.001 per share (the “Series B Preferred Stock”) and accompanying warrants (“Warrants”) to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) may be purchased for an aggregate purchase price of up to $8.0 million in one or more closings (each a “Closing”).
View on SEC.gov